Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOXOPHARM LIMITED Director's Dealing 2016

Aug 9, 2016

65437_rns_2016-08-09_61222acb-2a3e-4915-9de8-fec0c2eefa6d.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: Noxopharm Limited (ASX: NOX) ABN: 50 608 966 123

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Graham Kelly
Date of Appointment: 27 October, 2015

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

  • See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 1

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances giving rise tothe relevant interest. Number Class of Securities
Milligene Pty Ltd <The GE & PRKelly Family Trust>(Director Related Entity)Phytose Corporation Limited ATFBoundaryone Superannuation Fund(Director Related Entity)Bende Holdings Pty Ltd(Director Related Entity)Prudence Kelly(Director Spouse) 24,150,00012,075,0006,877,568175,00010,00010,000 Fully Paid Ordinary Shares– Escrowed until 8 Aug 2018Options– Escrowed until 8 Aug 2018Performance Shares– Escrowed until 8 Aug 2018Fully Paid Ordinary SharesFully Paid Ordinary SharesFully Paid Ordinary Shares

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
No. and class of securities towhich interest relates N/A

==> picture [42 x 25] intentionally omitted <==

Tuesday, 9[th] August 2016

  • See chapter 19 for defined terms.

11/3/2002

Appendix 3X Page 2